2Tsujimoto Y,Cossman J,Jaffe E,er al. Involvenent of the bcl-2 gene in human follicular lymphoma[J].Science,1985,228(4706):1440.
3Uz GL,Swerdlow SH. Distinction of follicular hyperplasis from follicular lymphoma in B5-fixed tissues:comparison of MF-2 and bcl-2 antibodies[J]. Hum Pathol,1993,24(11):1155.
4Jemmings CD,Foon KA. Recent advances in flowcytometry:application to the diagnosis of hematologic malignancy[J].Blood,1997,90(8):2863.
5Mclaughlin P,Grillo lopez AJ,Link BK,et al. Rituximab chimerie anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:half of patients respond to a four dose treatment program[J]. J Clin Oncol,1998,16(8):2825.
6Czuczman MS,Grillo Lopez AJ,White CA,et al.Treatment of patients with low-grade B-cell Lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy[J].J Clin Onco,1999,17(1):268.
7Kozopas KM,Yang T,Buchan HI,et al.Mcl21,a gene expression in programmed myeloid cell differentiation,has sequence similarity to bcl-2[J].Proc Natl Acad Sci USA,1993,90(8):3516.
8Schlaifer D,Krajewski S,Galoin S,et al . Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodefiency virus infection[J].Am J Pathol,1996,149(1):177.
9许良中.使用肿瘤病理方法学[M].上海:上海医科大学出版社,1997.557.
10Schroer KR,Franssila KO. Atypical hyperplasia of lymph nodes: a follow-up study[J]. Cancer, 1979,44(3) : 1155.
